1. Anti-infection Epigenetics Metabolic Enzyme/Protease Apoptosis
  2. Antibiotic Protein Arginine Deiminase E1/E2/E3 Enzyme HIF/HIF Prolyl-Hydroxylase MDM-2/p53 Apoptosis
  3. Streptonigrin

Streptonigrin  (Synonyms: Bruneomycin)

Cat. No.: HY-124586 Purity: 99.20%
Handling Instructions Technical Support

Streptonigrin (Bruneomycin) is an orally active antibiotic and pan-PAD inhibitor, inhibiting PAD1, PAD2, PAD3 and PAD4 with IC50 of 48.3 μM, 26.1 μM, 0.43 μM and 2.5 μM, respectively. Streptonigrin inhibits SENP1 (IC50 of 0.518 μM) and reduces HIF1α. Streptonigrin increases p53 and Apoptosis. Streptonigrin shows antiviral activity against Rauscher murine leukemia virus. Streptonigrin has immunosuppressive effects. Streptonigrin has antitumor activity against osteosarcoma.

For research use only. We do not sell to patients.

Streptonigrin Chemical Structure

Streptonigrin Chemical Structure

CAS No. : 3930-19-6

Size Price Stock Quantity
500 μg In-stock
1 mg In-stock
5 mg   Get quote  
10 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 2 publication(s) in Google Scholar

Other Forms of Streptonigrin:

Top Publications Citing Use of Products

1 Publications Citing Use of MCE Streptonigrin

WB

    Streptonigrin purchased from MedChemExpress. Usage Cited in: Sci Signal. 2023 Mar 14;16(776):eabq3362.  [Abstract]

    Streptonigrin (SUMOylation agonist; 2, 4, 8 μM; 48 h) markedly increases the amount of IL-33 protein SUMOylation in Huh7 cells transfected with wild-type IL-33.

    View All Antibiotic Isoform Specific Products:

    View All HIF/HIF Prolyl-Hydroxylase Isoform Specific Products:

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Streptonigrin (Bruneomycin) is an orally active antibiotic and pan-PAD inhibitor, inhibiting PAD1, PAD2, PAD3 and PAD4 with IC50 of 48.3 μM, 26.1 μM, 0.43 μM and 2.5 μM, respectively. Streptonigrin inhibits SENP1 (IC50 of 0.518 μM) and reduces HIF1α. Streptonigrin increases p53 and Apoptosis. Streptonigrin shows antiviral activity against Rauscher murine leukemia virus. Streptonigrin has immunosuppressive effects. Streptonigrin has antitumor activity against osteosarcoma[1][2][3][4][5][6][7][8][9][10].

    IC50 & Target[4]

    HIF-1α

     

    Cellular Effect
    Cell Line Type Value Description References
    A549 IC50
    0.33 μg/mL
    Compound: 1
    Cytotoxicity against Homo sapiens (human) A549 cells after 72 hr by MTT assay
    Cytotoxicity against Homo sapiens (human) A549 cells after 72 hr by MTT assay
    10.1007/s00044-004-0032-8
    A549 IC50
    0.33 μg/mL
    Compound: Streptonigrin
    In vitro cytotoxic activity against A 549 (non-small cell lung) using SRB (sulforhodamine B) assay
    In vitro cytotoxic activity against A 549 (non-small cell lung) using SRB (sulforhodamine B) assay
    [PMID: 10328288]
    CAKI-1 IC50
    0.4 nM
    Compound: 1
    Cytotoxicity against CD30 deficient and CD70 expressing human Caki1 cells after 96 hrs by resazurin conversion assay
    Cytotoxicity against CD30 deficient and CD70 expressing human Caki1 cells after 96 hrs by resazurin conversion assay
    [PMID: 19386499]
    HCT-15 IC50
    0.02 μg/mL
    Compound: 1
    Cytotoxicity against Homo sapiens (human) HCT15 cells after 72 hr by MTT assay
    Cytotoxicity against Homo sapiens (human) HCT15 cells after 72 hr by MTT assay
    10.1007/s00044-004-0032-8
    HCT-15 IC50
    0.02 μg/mL
    Compound: Streptonigrin
    In vitro cytotoxic activity against HCT-15 (colon) using SRB (sulforhodamine B) assay
    In vitro cytotoxic activity against HCT-15 (colon) using SRB (sulforhodamine B) assay
    [PMID: 10328288]
    KARPAS-299 IC50
    0.4 nM
    Compound: 1
    Cytotoxicity against CD30 expressing and CD70 deficient human KARPAS299 cells after 96 hrs by resazurin conversion assay
    Cytotoxicity against CD30 expressing and CD70 deficient human KARPAS299 cells after 96 hrs by resazurin conversion assay
    [PMID: 19386499]
    SK-MEL-2 IC50
    0.02 μg/mL
    Compound: 1
    Cytotoxicity against Homo sapiens (human) SK-MEL-2 cells after 72 hr by MTT assay
    Cytotoxicity against Homo sapiens (human) SK-MEL-2 cells after 72 hr by MTT assay
    10.1007/s00044-004-0032-8
    SK-MEL-2 IC50
    0.02 μg/mL
    Compound: Streptonigrin
    In vitro cytotoxic activity against SK-MEL-2 (melanoma) using SRB (sulforhodamine B) assay
    In vitro cytotoxic activity against SK-MEL-2 (melanoma) using SRB (sulforhodamine B) assay
    [PMID: 10328288]
    SK-OV-3 IC50
    0.28 μg/mL
    Compound: 1
    Cytotoxicity against Homo sapiens (human) SKOV3 cells after 72 hr by MTT assay
    Cytotoxicity against Homo sapiens (human) SKOV3 cells after 72 hr by MTT assay
    10.1007/s00044-004-0032-8
    SK-OV-3 IC50
    0.28 μg/mL
    Compound: Streptonigrin
    In vitro cytotoxic activity against SK-OV-3 (ovarian) using SRB (sulforhodamine B) assay
    In vitro cytotoxic activity against SK-OV-3 (ovarian) using SRB (sulforhodamine B) assay
    [PMID: 10328288]
    T-cell IC50
    < 20 μM
    Compound: 1, NSC-45383
    Inhibition of JAK-mediated IL6-induced Stat1 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry
    Inhibition of JAK-mediated IL6-induced Stat1 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry
    [PMID: 18157122]
    T-cell IC50
    < 20 μM
    Compound: 1, NSC-45383
    Inhibition of JAK-mediated IL10-induced Stat3 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry
    Inhibition of JAK-mediated IL10-induced Stat3 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry
    [PMID: 18157122]
    T-cell IC50
    < 20 μM
    Compound: 1, NSC-45383
    Inhibition of JAK-mediated interferon-gamma-induced Stat1 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry
    Inhibition of JAK-mediated interferon-gamma-induced Stat1 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry
    [PMID: 18157122]
    T-cell IC50
    < 20 μM
    Compound: 1, NSC-45383
    Inhibition of JAK-mediated IL6-induced Stat3 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry
    Inhibition of JAK-mediated IL6-induced Stat3 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry
    [PMID: 18157122]
    T-cell IC50
    < 20 μM
    Compound: 1, NSC-45383
    Inhibition of JAK-mediated IL15-induced Stat5 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry
    Inhibition of JAK-mediated IL15-induced Stat5 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry
    [PMID: 18157122]
    T-cell IC50
    < 20 μM
    Compound: 1, NSC-45383
    Inhibition of JAK-mediated IL7-induced Stat5 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry
    Inhibition of JAK-mediated IL7-induced Stat5 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry
    [PMID: 18157122]
    T-cell IC50
    < 20 μM
    Compound: 1, NSC-45383
    Inhibition of JAK-mediated IL4-induced Stat6 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry
    Inhibition of JAK-mediated IL4-induced Stat6 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry
    [PMID: 18157122]
    T-cell IC50
    < 20 μM
    Compound: 1, NSC-45383
    Inhibition of JAK-mediated IL4-induced Stat5 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry
    Inhibition of JAK-mediated IL4-induced Stat5 phosphorylation in BALB/c mouse CD4+ T cells by Phospho-Flow cytometry
    [PMID: 18157122]
    T-cell IC50
    < 20 μM
    Compound: 1, NSC-45383
    Inhibition of JAK-mediated IL6-induced Stat1 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry
    Inhibition of JAK-mediated IL6-induced Stat1 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry
    [PMID: 18157122]
    T-cell IC50
    < 20 μM
    Compound: 1, NSC-45383
    Inhibition of JAK-mediated IL10-induced Stat3 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry
    Inhibition of JAK-mediated IL10-induced Stat3 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry
    [PMID: 18157122]
    T-cell IC50
    < 20 μM
    Compound: 1, NSC-45383
    Inhibition of JAK-mediated IL6-induced Stat3 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry
    Inhibition of JAK-mediated IL6-induced Stat3 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry
    [PMID: 18157122]
    T-cell IC50
    < 20 μM
    Compound: 1, NSC-45383
    Inhibition of JAK-mediated IL15-induced Stat5 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry
    Inhibition of JAK-mediated IL15-induced Stat5 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry
    [PMID: 18157122]
    T-cell IC50
    < 20 μM
    Compound: 1, NSC-45383
    Inhibition of JAK-mediated IL7-induced Stat5 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry
    Inhibition of JAK-mediated IL7-induced Stat5 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry
    [PMID: 18157122]
    T-cell IC50
    < 20 μM
    Compound: 1, NSC-45383
    Inhibition of JAK-mediated IL4-induced Stat6 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry
    Inhibition of JAK-mediated IL4-induced Stat6 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry
    [PMID: 18157122]
    T-cell IC50
    < 20 μM
    Compound: 1, NSC-45383
    Inhibition of JAK-mediated IL4-induced Stat5 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry
    Inhibition of JAK-mediated IL4-induced Stat5 phosphorylation in BALB/c mouse CD8+ T cells by Phospho-Flow cytometry
    [PMID: 18157122]
    XF498 IC50
    0.31 μg/mL
    Compound: 1
    Cytotoxicity against Homo sapiens (human) XF498 cells after 72 hr by MTT assay
    Cytotoxicity against Homo sapiens (human) XF498 cells after 72 hr by MTT assay
    10.1007/s00044-004-0032-8
    XF498 IC50
    0.31 μg/mL
    Compound: Streptonigrin
    In vitro cytotoxic activity against XF 498 (CNS) using SRB (sulforhodamine B) assay
    In vitro cytotoxic activity against XF 498 (CNS) using SRB (sulforhodamine B) assay
    [PMID: 10328288]
    In Vitro

    Streptonigrin (10 μM) shows cytotoxicity towards both cancerous U2OS and normal NIH 3T3 cell lines[1].
    Streptonigrin (0-5 μM; 24 h) inhibits the proliferation of SW480 cells, AGS cells and HEK293 cells transfected with β-catenin in a dose-dependent manner[2].
    Streptonigrin (0.1-5 μM) does not influence the basal activity of soluble guanylate cyclase but causes concentration-dependent inhibition of enzyme activation by SNP (IC50 of 4.16 μM) and also by spermineNONO[3].
    Streptonigrin (0-1 μM; 10 min) inhibits SENP1 activity with an IC50 of 0.518 μM when SUMO1 is used as a substrate[4].
    Streptonigrin (2 μM; 16 h) reduces HIF1α protein level in HCT116 cells transfected with HIF1α expression plasmid[4].
    Streptonigrin (1 nM-10 μM; 4 h) shows a concentration-dependent effect on nuclear morphology in NIH 3T3 cells, promoting heterochromatin formation[5].
    Streptonigrin (2.5-500 μM; 60 min) inhibits the catalytic activity of purified calf thymus DNA topoisomerase II by relaxation of pBR322 DNA[6].
    Streptonigrin (72 h) selectively suppresses B-cell proliferation induced by LPS, with an IC50 value of 0.29 ng/mL[8].
    Streptonigrin (10-100 nM) increases p53 and Apoptosis in ACHN and CAKI-1 cells[9].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Viability Assay[8]

    Cell Line: A20.2J, M12.4.5, YAC-I, P815, FDC.P2
    Concentration:
    Incubation Time: 48 h
    Result: Showed relatively low inhibitory effect on the proliferation of A20.2J cells, with an IC50 value of 10.9 ng/mL.
    Showed relatively low inhibitory effect on the proliferation of M12.4.5 cells, with an IC50 value of 28.8 ng/mL.
    Showed inhibitory effect on the proliferation of YAC-I cells, with an IC50 value of 0.3 ng/mL.
    Showed a certain inhibitory effect on the proliferation of P815 cells, with an IC50value of 0.78 ng/mL.
    Had a good inhibitory effect on the proliferation of FDC.P2 cells, with an IC50value of 0.07 ng/mL.
    In Vivo

    Streptonigrin (0.2 mg/kg; i.p or 0.5 mg/kg; p.o.) shows antiviral activity in mice infected with the Rauscher murine leukemia virus, reducing the spleen weight[7].
    Streptonigrin (0.1-0.2 mg/kg; i.p.; on day 0, 2, 4, and 6; until day 7) significantly suppresses the proliferative response of T-cells rather than that of B-cells in C57BL/6 mice[8].
    Streptonigrin (0.1 mg/kg; p.o.; once a day; 5 days a week) increases the expression of p53 in tumors, and decreases the expression of Ki67 in the xenograft model of human renal cell carcinoma in BALB/c nude mice[9].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Female BALB/c mice (5-week-old) infected with Rauscher murine leukemia virus[7]
    Dosage: 0.05 mg/kg, 0.2 mg/kg, 0.5 mg/kg
    Administration: i.p. or p.o.
    Result: Significantly reduced splenomegaly, with the maximum effect at 0.2 mg/kg i.p. or 0.5 mg/kg p.o..
    Prolonged the survival time of infected mice.
    Molecular Weight

    506.46

    Formula

    C25H22N4O8

    CAS No.
    Appearance

    Solid

    Color

    Light brown to brown

    SMILES

    O=C(C1=NC(C2=NC3=C(C(C(OC)=C(N)C3=O)=O)C=C2)=C(N)C(C4=CC=C(OC)C(OC)=C4O)=C1C)O

    Structure Classification
    Initial Source

    Streptomyces flocculus

    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 6 months
    -20°C 1 month
    Purity & Documentation

    Purity: 99.20%

    References
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass   Concentration   Volume   Molecular Weight *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Streptonigrin
    Cat. No.:
    HY-124586
    Quantity:
    MCE Japan Authorized Agent: